Balaxi Pharmaceuticals discloses KMPs authorized to determine event materiality under SEBI Listing Regulations 30(5).
Chairman & MD Ashish Maheshwari and Company Secretary Aman Purohit are the two authorized KMPs.
Disclosure filed with NSE on March 25, 2026, as a compliance intimation under SEBI LODR Regulations 2015.